Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection

Peptides

Volumn 40, Issue , 2013, Pages 77-81

  Cirioni, Oscar ^a   Mocchegiani, Federico ^a   Cacciatore, Ivana ^b   Vecchiet, Jacopo ^b   Silvestri, Carmela ^a   Baldassarre, Leonardo ^b   Ucciferri, Claudio ^b   Orsetti, Elena ^a   Castelli, Pamela ^a   Provinciali, Mauro ^c   Vivarelli, Marco ^a   Fornasari, Erika ^b   Giacometti, Andrea ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c INRCA   (Italy)

Author keywords

Bacterial biofilm; Daptomycin; FS3; Lipopeptides; Vascular graft infection

Indexed keywords

AGAR; ALANINE; ANTIBIOTIC AGENT; DACRON; DAPTOMYCIN; FS 3; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

ADHERENT CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BIOFILM; COLONY FORMING UNIT; CONTROLLED STUDY; DACRON VASCULAR PROSTHESIS; DRUG EFFICACY; DRUG POTENTIATION; GRAFT INFECTION; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ANALYSIS; QUORUM SENSING; RAT; STAPHYLOCOCCUS INFECTION; SUBCUTANEOUS TISSUE; ULTRASOUND;

ANIMALS; DAPTOMYCIN; DISEASE MODELS, ANIMAL; HUMANS; MALE; PROSTHESES AND IMPLANTS; QUORUM SENSING; RATS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VASCULAR GRAFTING;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS; RATTUS NORVEGICUS; STAPHYLOCOCCUS AUREUS SUBSP. AUREUS STRAIN SMITH;

EID: 84876974977     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.12.002     Document Type: Article

References (39)

1. M.G. Ammendolia, R.D. Rosa, L. Montanaro, C.R. Arciola, and L. Baldassarri Slime production and expression of slime-associated antigen by staphylococcal clinical isolates J Clin Microbiol 37 1999 3235 3238
2. N. Balaban, T. Goldkorn, R.T. Nhan, L.B. Dang, S. Scott, and R.M. Ridgley Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus Science 280 1998 438 440
3. N. Balaban, Y. Gov, A. Giacometti, O. Cirioni, R. Ghiselli, and F. Mocchegiani A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci Antimicrob Agents Chemother 48 2004 2544 2550
4. L. Baldassarre, F. Pinnen, C. Cornacchia, E. Fornasari, L. Cellini, and M. Baffoni Synthesis of short cationic antimicrobial peptidomimetics containing arginine analogues J Pept Sci 18 2012 567 578
5. T.M. Bergamini Corpus Jr RA, McCurry TM, Peyton JC, Brittian KR, Cheadle WG. Immunosuppression augments growth of graft-adherent Staphylococcus epidermidis Arch Surg 130 1995 1345 1350
6. S. Bronner, H. Monteil, and G. Prévost Regulation of virulence determinants in Staphylococcus aureus: complexity and applications FEMS Microbiol Rev 28 2004 183 200
7. G.D. Christensen, W.A. Simpson, J.J. Younger, L.M. Baddour, F.F. Barrett, and D.M. Melton Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices J Clin Microbiol 22 1985 996 1006
8. O. Cirioni, A. Giacometti, R. Ghiselli, C. Bergnach, F. Orlando, and F. Mocchegiani Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection Peptides 27 2006 2104 2110
9. O. Cirioni, A. Giacometti, R. Ghiselli, G. Dell'Acqua, F. Orlando, and F. Mocchegiani RNAIII inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated S. aureus infections J Infect Dis 193 2006 180 186
10. O. Cirioni, A. Giacometti, R. Ghiselli, W. Kamysz, F. Orlando, and F. Mocchegiani Łukasiak J, Scalise G, Saba V. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection Peptides 27 2006 1210 1216
11. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6. Villanova, PA; 2003.
12. J.W. Costerton, L. Montanaro, and C.R. Arciola Biofilm in implant infections: its production and regulation Int J Artif Organs 28 2004 1062 1068
13. J.W. Costerton, P.S. Stewart, and E.P. Greenberg Bacterial biofilm: a common cause of persistent infections Science 284 1999 1318 1322
14. D.G. Davies Understanding biofilm resistance to antibacterial agents Nature 2 2003 114 122
15. D.G. Davies, M.R. Parsek, J.P. Pearson, B.H. Iglewski, J.W. Costerton, and E.P. Greenberg The involvement of cell-to-cell signals in the development of a bacterial biofilm Science 280 1998 295 298
16. R.M. Donlan, and J.W. Costerton Biofilms: survival mechanisms of clinically relevant microorganisms Clin Microbiol Rev 15 2002 167 193
17. O.A. Goeau-Brissonniere, D. Fabre, V. Leflon-Guibout, L. Di Centa, M.H. Nicolas-Chanoine, and M. Coggia Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses J Vasc Surg 35 2002 1260 1263
18. Y. Gov, A. Bitler, G. Dell'Acqua, J.V. Torres, and N. Balaban RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus: structure and function analysis Peptides 22 2001 1609 1620
19. L. Hall-Stoodley, J.W. Costerton, and P. Stoodley Bacterial biofilms: from the natural environment to infectious diseases Nat Rev Microbiol 2 2004 95 108
20. M.D. Kiran, N.V. Akidesavan, O. Cirioni, A. Giacometti, C. Silvestri, and G. Scalise Discovery of a quorum sensing inhibitor of drug resistant staphylococcal infections by structure-based virtual screening Mol Pharmacol 73 2008 1578 1586
21. M.D. Kiran, D.E. Akiyoshi, A. Giacometti, O. Cirioni, G. Scalise, and N. Balaban OpuC-an ABC transporter that is associated with Staphylococcus aureus pathogenesis Int J Artif Organs 32 2009 600 610
22. D.M. Livermore Has the era of untreatable infections arrived J Antimicrob Chemother 64 2009 i29 i36
23. T.F. Mah, and G.A. O'Toole Mechanisms of biofilm resistance to antimicrobial agents Trends Microbiol 9 2001 34 39
24. D.G. Maki Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention and management A.L. Bisno, F.A. Waldovogel, Infections associated with indwelling medical devices 1994 American Society for Microbiology Washington, DC 155 212
25. O. Murillo, C. Garrigos, M.E. Pachon, G. Euba, R. Verdaguer, and C. Cabellos Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 53 2009 4252 4257
26. N. Ni, M. Li, J. Wang, and B. Wang Inhibitors and antagonists of bacterial quorum sensing Med Res Rev 29 2009 65 124
27. O. Gara, and J.P.H. Humphreys Staphylococcus epidermidis biofilms: importance and implications J Med Microbiol 50 2001 582 587
28. F. Orlando, R. Ghiselli, O. Cirioni, D. Minardi, F. Tomasinsig Mocchegiani, and C. Silvestri BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection Peptides 29 2008 1118 1123
29. C.D. Owens, and K. Stoessel Surgical site infections: epidemiology, microbiology and prevention J Hosp Infect 70 2008 3 10
30. I. Raad, A. Alrahwan, and K. Rolston Staphylococcus epidermidis: emerging resistance and need for alternative agents Clin Infect Dis 26 1998 1182 1187
31. I. Raad, H. Hanna, Y. Jiang, T. Dvorak, R. Reitzel, and G. Chaiban Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant-Staphylococcus bacteremic isolates embedded in biofilm Antimicrob Agents Chemother 51 2007 1656 1660
32. F. Sardelic, P.Y. Ao, D.A. Taylor, and J.P. Fletcher Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron Cardiovasc Surg 4 1996 389 392
33. O. Simonetti, O. Cirioni, R. Ghiselli, G. Goteri, A. Scalise, and F. Orlando enhances healing of-wounds infected with methicillin resistant Staphylococcus aureus Antimicrob Agents Chemother 52 2008 2205 2211
34. J.N. Steenbergen, J. Alder, G.M. Thorne, and F.P. Tally Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections J Antimicrob Chemother 55 2005 283 288
35. J.N. Steenbergen, J.F. Mohr, and G.M. Thorne Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal studies J Antimicrob Chemother 64 2009 1130 1138
36. P.S. Stewart, W.M. Davison, and J.N. Steenbergen Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm Antimicrob Agents Chemother 53 2009 3505 3507
37. S. Stepanovic, D. Vukovic, I. Dakic, B. Savic, and M. Svabic-Vlahovic A modified microtiter-plate test for quantification of staphylococcal biofilm formation J Microbiol Methods 40 2000 175 179
38. C. Von Eiff, C. Heilmann, and G. Peters New aspects in the molecular basis of polymer-associated infections due to staphylococci Eur J Clin Microbiol Infect Dis 18 1999 853 856
39. C. Vuong Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis J Infect Dis 188 2003 706 718